Scott Vold
RenalogicScott is an experienced entrepreneur and operator of investor-backed healthcare companies. He joined Renalogic in August 2021 as the company’s Chief Commercial Officer, where he is responsible for the company's commercial growth. In that capacity, Scott leads the company's go-to-market, revenue generation and client acquisition functions.
Prior to Renalogic, Scott drove an industry-wide effort to redefine the physician referral management process as Founder, CEO, and Chairman of Fibroblast, Inc., a venture-funded company he led from concept to successful acquisition by Cerner Corporation (NASDAQ: CERN) in October 2020. He began his career as an attorney representing Fortune 1000 companies and financial services firms in complex commercial litigation. Scott lives in Chicago with his wife and children.